Literature DB >> 20367978

Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.

Li-juan Feng1, Zhe Wan, Xiao-hong Wang, Ruo-yu Li, Wei Liu.   

Abstract

BACKGROUND: The cytochrome P450 lanosterol 14alpha-demethylase (Erg11p) encoded by ERG11 gene is the primary target for azole antifungals. Changes in azole affinity of this enzyme caused by amino acid substitutions have been reported as a mechanism of azole antifungal resistance. This study aimed to investigate the relationship between amino acid substitutions in Erg11p from fluconazole resistant Candida albicans (C. albicans) isolates and their cross-resistance to azoles.
METHODS: Mutations in ERG11 gene were screened in 10 clinical isolates of fluconazole resistant C. albicans strains. DNA sequence of ERG11 was determined by PCR based DNA sequencing.
RESULTS: In the 10 isolates, 19 types of amino acid substitutions were found, of which 10 substitutions (F72S, F103L, F145I, F198L, G206D, G227D, N349S, F416S, F422L and T482A) have not been reported previously. Mutations in ERG11 gene were detected in 9 isolates of fluconazole resistant C. albicans, but were not detected in 1 isolate.
CONCLUSIONS: Although no definite correlation was found between the type of amino acid substitutions in Erg11p and the phenotype of cross-resistance to azoles, the substitutions F72S, F145I and G227D in our study may be highly associated with resistance to azoles because of their special location in Erg11p.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367978

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.

Authors:  Dominique Sanglard; Alix T Coste
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 2.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

3.  Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.

Authors:  Jamel Eddouzi; Josie E Parker; Luis A Vale-Silva; Alix Coste; Françoise Ischer; Steve Kelly; Mohamed Manai; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

4.  Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.

Authors:  Jinqing Zhang; Wei Liu; Jingwen Tan; Yi Sun; Zhe Wan; Ruoyu Li
Journal:  Mycopathologia       Date:  2013-01-23       Impact factor: 2.574

5.  Global Screening of Genomic and Transcriptomic Factors Associated with Phenotype Differences between Multidrug-Resistant and -Susceptible Candida haemulonii Strains.

Authors:  Hao Zhang; Yifei Niu; Jingwen Tan; Weixia Liu; Ming-An Sun; Ence Yang; Qian Wang; Ruoyu Li; Yejun Wang; Wei Liu
Journal:  mSystems       Date:  2019-12-17       Impact factor: 6.496

Review 6.  Petrositis caused by fluconazole-resistant candida: case report and literature review.

Authors:  Ling Jin; Shuangxi Liu; Shiwang Tan; Yang Wang; Yumin Zhao; Shaoqing Yu
Journal:  BMC Infect Dis       Date:  2022-07-27       Impact factor: 3.667

7.  Azole resistance in Candida spp. isolated from Catú Lake, Ceará, Brazil: an efflux-pump-mediated mechanism.

Authors:  Raimunda S N Brilhante; Manoel A N Paiva; Célia M S Sampaio; Débora S C M Castelo-Branco; Carlos E C Teixeira; Lucas P de Alencar; Tereza J P G Bandeira; André J Monteiro; Rossana A Cordeiro; Waldemiro A Pereira-Neto; José J C Sidrim; José L B Moreira; Marcos F G Rocha
Journal:  Braz J Microbiol       Date:  2016-01-27       Impact factor: 2.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.